Johnson & Johnson honored in Fast Company’s top ten most innovative biotech companies

February 13, 2017

Johnson & Johnson was honored as one of Fast Company’s top ten most innovative biotech companies. Johnson & Johnson was recognized for its incubation of medical startups. Learn more about the ranking on Fast Company’s website. Check out JLABS to learn more about how we support startups.

More from Johnson & Johnson

Health & wellness

October 29, 2025

Juvenile myasthenia gravis: Inside one adolescent’s journey

The condition is typically diagnosed in adults, but research suggests an uptick in adolescent patients. Learn more about the rare autoantibody disease, how one teen is managing it and why Johnson & Johnson is working to improve treatment options for patients of all ages.

Innovation

October 28, 2025

5 ways Johnson & Johnson is innovating in medicines and therapies

From rare diseases to all-too-common cancers, Johnson & Johnson is on a mission to improve treatment options for people around the globe. Learn more about how the company is working to create new therapies for IBD, lung cancer, major depressive disorder, bladder cancer, myasthenia gravis and more.

Our company

October 22, 2025

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community

Teaming up to support healthcare in the local community and empower residents.

Search Results

No Results

Johnson & Johnson honored in Fast Company’s top ten most innovative biotech companies

More from Johnson & Johnson

Juvenile myasthenia gravis: Inside one adolescent’s journey

5 ways Johnson & Johnson is innovating in medicines and therapies

Johnson & Johnson to collaborate with the New York Jets to promote better health in the community